University of Alabama at Birmingham, Birmingham , United States

Matthew Alexander is Associate Professor and serves as the UAB Center for Exercise Medicine (UCEM) Education Chair. His laboratory focuses on identifying novel epigenetic and genetic regulators of human neuromuscular diseases and generating novel zebrafish models of disease for drug screening purposes.

Westmead Children's Hospital, Maroubra , Australia

Catholic University of Sacred Heart - Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome , Italy

Mayo Clinic, Rochester , United States

Dr. Liewluck is a Professor of Neurology at the Mayo Clinic College of Medicine in Rochester, Minnesota, USA. He obtained his medical degree from the Faculty of Medicine, Siriraj Hospital, Mahidol University in Thailand, and pursued a neuromuscular research fellowship at the National Center of Neurology and Psychiatry of Japan under the directorship of Professor Ichizo Nishino. He furthered his expertise with a neurology residency at the University of Miami Miller School of Medicine, followed by dual fellowships in Clinical Neurophysiology (EMG) and Muscle Diseases at the Mayo Clinic in Rochester under the directorship of the late Professor Andrew G. Engel. Dr. Liewluck holds board certifications in Neurology, Neuromuscular Medicine, and Clinical Neuromuscular Pathology. His clinical practice and research focus on a comprehensive understanding of muscle diseases, particularly acquired myopathies. He has authored over 130 peer-reviewed articles and nine book chapters and co-edited one book. Dr. Liewluck is actively involved in professional organizations such as the WMS, AAN, ANA, AANEM, IMACS, and IMyoS. He served as chair of the ANA Neuromuscular Disease Special Interest Group in 2023, vice chair of the AAN Neuromuscular Section from 2023 to 2025, and vice chair of the IMACS Scientific Committee from 2023 to 2025. Dr. Liewluck currently chairs the Abstract Review Committee of the AANEM and is an associate board member of IMyoS.

The Sydney Children's Hospitals Network, Westmead , Australia

I am the Advanced Therapeutics Medical Lead at The Sydney Children’s Hospitals Network, leading the implementation and delivery of complex therapies and clinical trials, including gene and cell based therapies, for paediatric patients in New South Wales and beyond. I am the Clinical Lead of the Neurogenetics and Neuromuscular Service at The Children's Hospital at Westmead and a Senior Clinical Lecturer at the University of Sydney. I am also a paediatric neurologist with a specific interest in gene replacement therapy and other innovative treatments for neurological conditions and rare disorders. I am an investigator on several gene therapy clinical trials for conditions including Duchenne muscular dystrophy, Rett Syndrome and metabolic diseases.

NIH/NINDS, North Bethesda , United States

POLICLINICO UNIVERSITARIO A. GEMELLI IRCCS, Roma RM , Italy

I am an Italian communication and project management professional working in the field of rare diseases. I am involved with the Fondazione Policlinico Universitario Agostino Gemelli IRCCS, where I serve as a coordinator and project manager in pediatric initiatives, focusing on awareness, inclusion, and quality of life for children with conditions such as neuromuscular diseases. I have contributed to the development of educational and support programs, including projects dedicated to families and women affected by neuromuscular disorders, in collaboration with clinical and research centers. I am also engaged in communication and community activities related to the World Duchenne Organization, helping to raise awareness and promote patient-centered initiatives at both national and international levels. My work combines storytelling, advocacy, and project design to support patients and families, fostering greater understanding of rare diseases and encouraging social inclusion.